Financial statements Ima Pharma
Balance sheet data of IMA PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 971 371,84 | 1 524 746,42 | 1 927 345,91 | 2 085 607,78 | 2 410 730,29 | 2 319 745,63 |
| A. Fixed assets | 3 902,50 | 65 084,33 | 111 334,55 | 123 979,35 | 141 833,76 | 129 484,78 |
| B. Current assets | 967 469,34 | 1 459 662,09 | 1 816 011,36 | 1 961 628,43 | 2 268 896,53 | 2 190 260,85 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 971 371,84 | 1 524 746,42 | 1 927 345,91 | 2 085 607,78 | 2 410 730,29 | 2 319 745,63 |
| A. Equity | 273 141,46 | 241 472,25 | 284 463,69 | 371 937,78 | 545 329,41 | 331 339,21 |
| B. Liabilities and provisions for liabilities | 698 230,38 | 1 283 274,17 | 1 642 882,22 | 1 713 670,00 | 1 865 400,88 | 1 988 406,42 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 673 493,45 | 1 257 929,18 | 1 594 753,72 | 1 664 389,32 | 1 734 541,11 | 1 876 286,34 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.